In 2023, the biopharmaceutical market in South East Asia was valued at US$ 18.4 billion. Projections indicate that the market will grow to US$ 37.6 billion by 2032, reflecting a compound annual growth rate (CAGR) of 8.25% from 2024 to 2032. https://www.imarcgroup.com/south-east-asia-biopharmaceutical-market